Cortechs.ai | Prediction of amyloid positivity using automated segmentation
Contact
  • Home
  • /
  • Insights
  • /
  • Prediction of amyloid positivity using automated segmentation

Prediction of amyloid positivity using automated segmentation

Prediction of amyloid positivity in mild cognitive impairment using fully automated brain segmentation software

The objective of this study was to assess the predictive ability of regional volume information provided by fully automated brain segmentation software for cerebral amyloid positivity in mild cognitive impairment (MCI). (2020).

[button]Download[/button]

  • Topic: Published research

Insights

Cortechs.ai | Prediction of amyloid positivity using automated segmentation
  • 3 mins

02/02/2025

NeuroQuant® Brain Tumor: Revolutionizing Neuro-Oncology with AI-Driven Precision

Dr. Suzie Bash and Dr. Jeff Rudie dive deep into the advanced functionalities and clinical benefits of the tool that is revolutionizing neuro-oncology

Cortechs.ai | Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye
  • < 1 mins

01/28/2025

Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Hear from CEO Kyle Frye on the SCALE Community Podcast about how Cortechs.ai is transforming healthcare with cutting-edge AI-powered medical imaging solutions.

,

Cortechs.ai | Prediction of amyloid positivity using automated segmentation
  • 3 mins

01/09/2025

Cortechs.ai Announces Oversubscribed Funding Round to Accelerate Innovation in AI-Powered Neuroimaging and Oncology Solutions

This investment propels our mission to revolutionize medical imaging in neuroimaging and oncology, enhancing diagnostic confidence and patient outcomes.

,

View our insights
Cortechs.ai | Prediction of amyloid positivity using automated segmentation
Cortechs.ai | Prediction of amyloid positivity using automated segmentation

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

  • Solutions
  • © Cortechs.ai 2024
Scroll to Top